The 2 types of surgeries are laser and filter surgery. Briefly describe the surgeries.
The filtering surgery which is also known as Trabeculectomy is a surgical procedure used in the treatment of glaucoma. Trabeculectomy is a conventional filtering (drainage) procedure which lowers IOP by creating a new channel (fistula) for aqueous outflow between the anterior chamber and sub-Tendon’s space without the use of an artificial device. The following are the two main types:
1.Partial-thickness (Trabeculectomy) in which the fistula is protected by a superficial scleral flap.
2.Full-thickness (Scheie’s thermosclerostomy) in which the fistula passes through the entire thickness of the sclera. Full thickness procedures are rarely performed now because a high percentage was complicated by postoperative hypotony and a flat anterior chamber.
Filtering surgery is usually indicated when the patient’s glaucoma is observed to worsen at the present level of intraocular pressure, usually after establishing maximum tolerated medical therapy, and possibly following laser trabeculoplasty.
The goal of guarded filtering surgery is to create a partial thickness scleral flap at the limbus overlying a hole punched through the remaining eye wall, effectively connecting the anterior chamber to the outside world. The scleral flap is sutured back into place, with tension on the sutures adjusted to allow a calculated flow out of the hole. The aqueous then collects under the conjunctiva, elevating it and forming a ‘bleb’. Aqueous leaks from this area into the veins and lymph vessels which lowers the IOP. The success of the surgery depends on a constant leak of aqueous through the scleral opening, and the integrity of conjunctival bleb, so there is no leak of aqueous onto the ocular surface. For this reason, during filtering surgery, the conjunctiva should be handled as little as possible and as meticulously as possible.
Process of Trabeculectomy
Step 1
Step 2
Step 3
Step 4
Step 1: ALimbal based flap is created by incising the conjunctival
Step 2: A scleral flap is created by incising the sclera, after which Sclerectomy is performed. It involved the excision of a deep rectangular block which may contain scleral spur, Schlemm’s canal, trabeculum, Schwalbe’s line and peripheral cornea.
Step 3: An incision is made into the anterior chamber to allow the outflow of aqueous.
Step 4: Suturing of the scleral flap and the Limbal based flap to prevent the leakage of aqueous outside of the ocular structure. Mitomycin C is used to inhibit the proliferation of fibroblast.
The laser surgery which is also known as argon laser trabeculoplasty is a procedure by which the application of discrete laser burns to the trabeculum. This creates evenly spaced burns in the trabecular meshwork which opens up the drainage angle and enhances aqueous outflow that lowers IOP.
Argon laser trabeculoplasty is generally indicated for the reduction of IOP in patients with primary open-angle glaucoma. It is indicated in uncontrolled glaucoma whereby IOP is uncontrolled with miotics. For patients who do not comply to medical therapy.
The procedure is contraindicated when the trabeculum is not visible due to extremely narrow/closed angle or corneal clouding. In advanced glaucoma where compliance to medical therapy is poor and there is insufficient time to assess the response to LT before proceeding to Trabeculectomy. Treatment is known to be ineffective, such as paediatric glaucoma and most secondary glaucoma with the exception of pigmentary glaucoma and pesudoexfoliation glaucoma. LT which has failed previously is also a contraindication for trabeculoplasty.
Process of Trabeculoplasty
Step 1: Laser is being ‘warmed up’ for 5 minutes. Patient is instilled with a drop of 1% apraclonidine to prevent early post-LT rise in IOP and 2 drops of topical anaesthetic.
Step 2: Identify the scleral spur and Schwalbe’s line and the 3D ground glass appearance of the trabeculum. Aim the beam at the junction of the pigmented and non-pigmented trabeculum.
Step 3: Apply 25 burns at regularly spaced intervals from one end to another.
The 2 types of surgeries are laser and filter surgery. Briefly describe the surgeries.
The filtering surgery which is also known as Trabeculectomy is a surgical procedure used in the treatment of glaucoma. Trabeculectomy is a conventional filtering (drainage) procedure which lowers IOP by creating a new channel (fistula) for aqueous outflow between the anterior chamber and sub-Tendon’s space without the use of an artificial device. The following are the two main types:
1.Partial-thickness (Trabeculectomy) in which the fistula is protected by a superficial scleral flap.
2.Full-thickness (Scheie’s thermosclerostomy) in which the fistula passes through the entire thickness of the sclera. Full thickness procedures are rarely performed now because a high percentage was complicated by postoperative hypotony and a flat anterior chamber.
Filtering surgery is usually indicated when the patient’s glaucoma is observed to worsen at the present level of intraocular pressure, usually after establishing maximum tolerated medical therapy, and possibly following laser trabeculoplasty.
The goal of guarded filtering surgery is to create a partial thickness scleral flap at the limbus overlying a hole punched through the remaining eye wall, effectively connecting the anterior chamber to the outside world. The scleral flap is sutured back into place, with tension on the sutures adjusted to allow a calculated flow out of the hole. The aqueous then collects under the conjunctiva, elevating it and forming a ‘bleb’. Aqueous leaks from this area into the veins and lymph vessels which lowers the IOP. The success of the surgery depends on a constant leak of aqueous through the scleral opening, and the integrity of conjunctival bleb, so there is no leak of aqueous onto the ocular surface. For this reason, during filtering surgery, the conjunctiva should be handled as little as possible and as meticulously as possible.
Process of Trabeculectomy
Step 1
Step 2
Step 3
Step 4
Step 1: ALimbal based flap is created by incising the conjunctival
Step 2: A scleral flap is created by incising the sclera, after which Sclerectomy is performed. It involved the excision of a deep rectangular block which may contain scleral spur, Schlemm’s canal, trabeculum, Schwalbe’s line and peripheral cornea.
Step 3: An incision is made into the anterior chamber to allow the outflow of aqueous.
Step 4: Suturing of the scleral flap and the Limbal based flap to prevent the leakage of aqueous outside of the ocular structure. Mitomycin C is used to inhibit the proliferation of fibroblast.
The laser surgery which is also known as argon laser trabeculoplasty is a procedure by which the application of discrete laser burns to the trabeculum. This creates evenly spaced burns in the trabecular meshwork which opens up the drainage angle and enhances aqueous outflow that lowers IOP.
Argon laser trabeculoplasty is generally indicated for the reduction of IOP in patients with primary open-angle glaucoma. It is indicated in uncontrolled glaucoma whereby IOP is uncontrolled with miotics. For patients who do not comply to medical therapy.
The procedure is contraindicated when the trabeculum is not visible due to extremely narrow/closed angle or corneal clouding. In advanced glaucoma where compliance to medical therapy is poor and there is insufficient time to assess the response to LT before proceeding to Trabeculectomy. Treatment is known to be ineffective, such as paediatric glaucoma and most secondary glaucoma with the exception of pigmentary glaucoma and pesudoexfoliation glaucoma. LT which has failed previously is also a contraindication for trabeculoplasty.
Process of Trabeculoplasty
Step 1: Laser is being ‘warmed up’ for 5 minutes. Patient is instilled with a drop of 1% apraclonidine to prevent early post-LT rise in IOP and 2 drops of topical anaesthetic.
Step 2: Identify the scleral spur and Schwalbe’s line and the 3D ground glass appearance of the trabeculum. Aim the beam at the junction of the pigmented and non-pigmented trabeculum.
Step 3: Apply 25 burns at regularly spaced intervals from one end to another.
(Illustration of laser trabeculoplasty
11:39 PM // Out of the darkness and into the sun
{ DOPT 2A/01 }
Names:
Jacky Lau Aik Meng - P0941790
Ng Qi rui - P0941873
Lau Jia Yang - P0941802
Delvin Chong - P0941688
Kang Kee Ching - P0941787
Paton Benjamin Nicholas - P0941208
Tan Tuan Tuan Mark - P0941659
Justin Ng Zhi Zhong - P0941899
Teoh Zeng Siong - P0966830 Class: DOPT 2A/01 Layout:evme
{ Methods }
Medical therapy for glaucoma
Treatment of glaucoma are available in different classes of topical ocular hypotensive medications.
They consist of: Prostaglandins
-Prostaglandin analogs like latanoprost (Xalatan), bimatoprost (Lumigan) and travoprost (Travatan) increase uveoscleral outflow of aqueous humor. Bimatoprost also increases trabecular outflow.
Beta-adrengeric receptor blocker
-Topical beta-adrenergic receptor antagonists such as timolol, levobunolol (Betagan), and betaxolol decrease aqueous humor production by the ciliary body.
Alpha agonist
-Alpha2-adrenergic agonists such as brimonidine (Alphagan) work by a dual mechanism, decreasing aqueous production and increasing trabecular outflow.
Mydriatics
-Less-selective sympathomimetics like epinephrine and dipivefrin (Propine) increase outflow of aqueous humor through trabecular meshwork and possibly through uveoscleral outflow pathway, probably by a beta2-agonist action.
Miotics
-Miotic agents (parasympathomimetics) like pilocarpine work by contraction of the ciliary muscle, tightening the trabecular meshwork and allowing increased outflow of the aqueous humour. Ecothiopate is used in chronic glaucoma.
Carbonic Anhydrase Inhibitors(CAI)
-Carbonic anhydrase inhibitors like dorzolamide (Trusopt), brinzolamide (Azopt), acetazolamide (Diamox) decrease secretion of aqueous humor by inhibiting carbonic anhydrase in the ciliary body.
Combination therapy
-More than 50% of glaucoma patient require 2 or more ocular hypotensive medications for adequate IOP control.
The mechanism by which each class reduces intraocular pressure is either by decreasing aqueous inflow or increasing outflow. Each class includes several different compounds and formulations, increasing the number of potential therapeutic options.
Glaucoma surgery
For Open angle glaucoma(primary or secondary), glaucoma surgery is only considered when medical therapy fails.
For closed angle glaucomas (primary or secondary) and infantile glaucomas, glaucoma surgery is the definitive treatment of choice and medical therapy serves to control IOP temporarily before the surgery
Treatment of primary closed angle glaucomas
•Peripheral iridotomy
The definitive treatment of choice for primary closed angle glaucoma is to create an opening in the iris. This opening in the iris will allow aqueous trapped behind the iris to enter the anterior chamber, deepening the anterior chamber and opening up the drainage angles.
•Laser iridoplasty
This technique requires putting several mild laser burns on the peripheral iris which will cause iris to contract. This will pull the peripheral iris away from the drainage angles, lowering the eye pressure and breaking the acute attack.
•Trabeculectomy
The most common conventional surgery performed for glaucoma is the trabeculectomy. Here, a partial thickness flap is made in the scleral wall of the eye, and a window opening made under the flap to remove a portion of the trabecular meshwork. The scleral flap is then sutured loosely back in place. This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye. Scarring can occur around or over the flap opening, causing it to become less effective or lose effectiveness altogether. One person can have multiple surgical procedures of the same or different types
•Cataract surgery
Another effective method in treating acute closed angle glaucoma is surgical removal of the lens. This technique used is usually a phacoemulsification cataract surgery with intraocular lens implant. The surgical wound is small and healing process is fast. By removing the lens, it deepens the drainage angles and open up the drainage angle instantly
Treatment of secondary closed angle glaucomas
The surgical treatment has to be directed at the cause of the glaucoma. If the cause of the secondary closed angle glaucoma is a wobbly lens, surgery will have to involve either a laser peripheral iridotomy or surgical removal of the wobbly lens. The eye surgeon will have to examine the patient and decide on the cause before contemplating on the most appropriate surgical therapy.
Treatment of primary open angle glaucomas
The mainstay treatment for primary open angle glaucoma is eye drops. However, when the eye pressure is not adequately controlled with eye drops and oral medication, the eye surgeon may contemplate performing laser treatment or surgery.
•Laser Trabeculoplasty
Laser treatment for primary open angle glaucoma is called laser trabeculoplasty. It is the procedure where laser burns are applied to he drainage angles and this increases the drainage of aqueous through trabecular meshwork . The most significant complications of this procedure is the transient rise in eye pressure which can cause further damage to the optic nerve.
•Trabeculectomy
( Refer to above )
Treatment of secondary open angle glaucomas
The mainstay of treatment of secondary open angle glaucomas is eyedrops. If eye drops and oral medication fail to control the eye pressure, the eye surgeon will have to contemplate surgical treatment. The types of surgery performed are similar to that for primary open angle glaucoma. However, due to the higher chance of failure for surgery, eye surgeons often perfrom trabeculectomy surgery with antimetabolites to reduce the incidence of scarring and subsequent surgical failure.
Other types of glaucoma surgeries
•Seton surgery
Another surgery that is performed for difficullt glaucoma cases( usually the secondary closed angle and secondary open angle glaucomas) is the seton surgery. It involves inserting a drainage device into the anterior chamber which allows aqueous to drain out into the space beneath the conjunctiva, allowing it to be absorbed by the conjunctival tissue and returned to the blood stream.
•Ciliary body destructive procedures
There are several surgical procedures that reduce aqueous production by destroying the aqueous producing part of eye. Generally, eye surgeons do not use this method unless the affected eye has very severe glaucoma with no visual potential. This is due to the high risk of complications such as excessively low pressure, severe pain , inflammation and shrinkage of the eye. There are many methods of ciliary destruction- some use freezing (cryotherapy), Argon laser, YAG laser, burning probes (diathermy) to achieve ciliary body destruction.
•Veterinary implant
TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR-ClarifEYE. The implant consists of a new biomaterial, the STAR BioMaterial, which consists of silicone with a very precise homogenous pore size, a property which reduces fibrosis and improves tissue integration. The implant contains no valves and is placed completely within the eye without sutures. To date, it has demonstrated long term success (> 1yr) in a pilot study in medically refractory dogs with advanced glaucoma
The modern goals of glaucoma management are to avoid glaucomatous damage, nerve damage, preserve visual field and total quality of life for patients with minimal side effects.This requires appropriate diagnostic techniques and follow up examinations and judicious selection of treatments for the individual patient. Although intraocular pressure is only one of the major risk factors for glaucoma, lowering it via various pharmaceuticals and/or surgical techniques is currently the mainstay of glaucoma treatment. Vascular flow and neurodegenerative theories of glaucomatous optic neuropathy have prompted studies on various neuroprotective therapeutic strategies including nutritional compounds some of which may be regarded by clinicians as safe for use now, while others are on trial.
Glaucoma treatment surgeries and procedures are a temporary solution. There is not yet a cure for glaucoma.
{ 6 types of glaucoma drugs }
Adrenergic Agonist
Adrenergic agonist is a drug that has similar effects or same as epinephrine (adrenaline) which makes it a sympathomimetic agent. It stimulates a response by binding to the receptor and are categorise in 5 different groups namely, α1, α2, β1, β2, and β3
Brimonidine tartate
•Mechanism
-Reduces the pressure in the eyes by reducing the amount of aqueous humour the eyes produce and also increase the amount of fluid that drains out of the eyes
•Clinical uses
-Used to treat high pressure in the eyes in people with open-angle glaucoma.
-Used to prevent high pressure in the eye after laser surgery for glaucoma.
•Ocular effects
-Itching of the eye
-Redness and stinging in the eyes
-1 drop in affected eye 3 times daily for glaucoma, ocular hypertension patients.
•Contraindications
-Not able to use with monoamine oxidase (MAO) inhibitor therapy.
-Hypersensitivity to brimonidine tartrate or any other components of the formulation.
•Precautions
-Patients with depression, renal impairment, hepatic should not exercise after application.
-Excreted in breast milk in animal studies.
-Patients wearing contact lenses should wait 15mins before inserting them in after application.
Apraclonidine hydrochloride
•Mechanism
-An ocular alpha adrenergic agent that is a relatively selective for alpha₂ receptor agonist.
-Reduces intraocular pressure.
-It starts to stimulate actions within an hour of usage.
•Clinical uses
-Uses to treat glaucoma
-Intraocular hypertension, post-laser surgery
-Postcyclopledic intraocular pressure spikes
-Intraocular pressure from post-cataract surgery
•Ocular effects
-Eye discomfort
-Redness around eye
-Conjunctivitis
-Changes in visual acuity
-Mydriasis
-Ocular inflammation
•Systemic effects
-Dry mouth
-Headache
-Nasal decongestion
•Indications
-1 drop to affected eye 3 times daily for glaucoma treatment
-1 drop an hour before surgery and another after for post-laser surgery
•Contraindications
-Hyper-sensitivity to apraclonidine or clonidine or any components of the formulation
•Precautions
-Aphraclonidine hydrochloride causes dizziness, somnolence and decreased mental alertness
-Patients with depression should avoid
Dipivefrin Hydrochloride
•Mechanism
-Penetrates in the anterior chamber with its lipophilic character
-Reduces intraocular pressure
-Occurs within 30minutes of usage; peak effect in an hour
-Dipvefrin is converted to epinphrin inside the eye by enzyme hydrolysis
•Clinical uses
-Use to treat open angle glaucoman
•Ocular effects
-Blurred vision
-Burning/stinging of eye
-Mydriasis
-Follicular conjunctivitis
•Systemic effects
-Headache
•Indications
-For open-angle glaucoma patients, 1 drops of the solution to the eye every 12 hours.
•Contraindications
-Not suitable for narrow-angle glaucoma
-Hypersensitivity to dipivefrin or any component of the formulation
•Precautions
-Macular edema occurred before in aphakic patients treated with epipherin.
-Narrow-angle glaucoma patients should not be administrated with dipivefrin as the angle might close.
Hyperosmotic agents
Hyperosmotic agent is a drug that makes blood plasma hypertonic thus drawing fluid out of the eye and leading to a reduction in intraocular pressure. It is used in the treatment of angle-closure glaucoma and sometimes before surgery to decrease the intraocular pressure.
Glycerin
•Mechanism
-Glycerin increases osmostic pressure and draws fluid into colon and stimulates evaulcation of inspissated feces.
-Lowering both the intraocular & intracranial pressure by osmostic hydrating effect.
-Ischemic areas have their blood flow increased
-A drop in serum free fatty acid and an increase of glycerides production in the brain.
-Widely distributed to extracellular space and metabolize in the liver.
•Clinical uses
-Reduces intraocular pressure
-Reduces intracranial pressure
-Can be use for viral meningoencephalitis
-1-2 drops every 3-4 hours befor examination for ophthalmologic procedures.
-1.5g/kg/day every 4 hours to reduce intracranial pressure
-1.8g/kg/day every 1-1.5 hours to reduce intraocular pressure
•Contraindications
-Hypersensitivity to any component in the preparation of glycerin
•Precautions
-Anaesthetic should be used shortly after as glycerine is an irritant
-Always change cap after using.
-Contact lens to be removed before use for glycerine
-If eye shows symptoms of irritation, redness, changes in vision acuity stop use and consult and eye specialist.
Isosorbide
•Mechanism
-Stimulates intracellular cyclic guanosine monophosphate (GMP.)
-Relaxes vascular smooth muscle of both arterial and venous vasculature
-Well absorb after PO(by mouth) administration
•Clinical uses
-Acute-angle glaucoma
•Ocular effects
-Blurred vision
•Systemic effects
-Burning & tingling at oral point
-Transient flushing of face and neck
-Dizziness
-Weakness
-Postural hypotension
-Nausea
-Vomiting
-Restlessness
-Dry mouth
-GI(Gastrointestinal) upset
•Indications
-Treatment of acute angle-closure glaucoma in emergency situations
•Contraindications
-Closed-angle glaucoma
-Hypersensitivity to nitrates
•Precautions
-Patients with salt retention disease should use repetitive dose with caution.
-Bladder to be empty before surgery
Mannitol
•Mechanism
-Elevates osmostic pressure of the glomerular filtrate, inhibiting tubular reabsorption of water and electrolytes resulting in increased flow of water into interstitial fluid and plasma.
•Clinical uses
-To treat acute angle glaucoma by decreasing the intraocular pressure
-Initially, patients takes 0.5-1g/kg and after takes 0.25/0.5g/kg every 4-6 hours for acute glaucoma
-Mannitol can be use to dehydrate the vitreous and overcome malignant glaucoma and refractory intraocular pressure elevation
-Clinical evaluation and periodic laboratory determinations are necessary to moniter changes in fluid balance, electrolytes concentrations and acid-base balance.
-Mannitol to be used with care on patient who is suffering from hypervolemia, renal insufficiency, urinary tract obstruction, or impending or frank cardiac decompensation.
-Mannitol administration may obscure and intensify inadequate hydration or hypovelemia by sustaining diuresis.
Carbonic Anhydrase Inhibitors (CAIs)
The CAIs (Carbonic Anhydrase Inhibitors) can be taken in orally or in the form of eye-drops. It suppresses the activity of carbonic anhydrase and also serves as a short-term use in cataract surgery. It can be used in selected cases of macular edema, and as an ocular pressure-lowering drug (anti-glaucoma agents).
Acetazolamide
•Mechanism
-A carbonic anhydrase inhibitor that reduces formation of hydrogen and bicarbonate ions from carbon dioxide and water by inhibiting, in proximal renal tubule, the enzyme carbonic anhydrase, thereby promoting renal excretion of sodium, potassium, bicarbonate and water.It reduces the rate of aqueous humor formation hence resulting in the lowering of intraocular pressure (IOP)
•Clinical uses
-Treatment of glaucoma
-Treatment of ocular edema
-Treatment of centrencephalic epilepsies
-The drug should be used as an adjunct to the usual therapy. The dosage used in treatment of chronic imple (open-angle) glaucoma ranges from 250mg to 1g of acetazolamide per 24 hours, usually in divided doses for amounts over 250mg. A dosage in excess of 1g per 24 hours usually does not produce an increased effect. In all cases, adjustment of the dosage according to careful individual symptomatology and ocular tension. In treatment of secondary glaucoma and in the preoperative treatment of some cases of acute congestive (closed-angle) glaucoma, the recommended dosage would be 250mg every 4 hours. In some acute cases, it may be more satisfactory to administer an initial dose of 500mg followed by 125mg every 4 hours depending on several individual cases.
•Contraindications
-Severe renal disease
-Adrenal insufficiency
-Hypochloremic acidosis
-Hypersensitivity to the drug itself or any other components of the formulations.
-It has several interactions with other drugs such as lithium and digoxin, and diagnostic test effects such as increasing ammonia, uric acid and a decrease in bicarbonate potassium. However, there’re no known interactions with any herbal or food. There’re no incompatibilities and compatibilities with cimetidine, procaine and ranitidine.
•Precautions
-Increasing the dose would not help increase diuresis and it may increase the incidence of drowsiness and/or paresthesia.
-By increasing the dose often would result in a decrease in diuresis. Very large doses are also given with other diuretics to secure diuresis in complete refractory failure under certain circumstances.
-Adverse reactions might be noted, and precautions are advised for early detections of such reactions.
Brinzolamide
•Mechanism
-An ophthalmic agent that inhibits carbonic anhydrase. It decreases aqueous humor secretion and its therapeutic effect is reducing of intraocular pressure (IOP).
-It is recommended that the adults/elderly instill 1 drop in affected eye(s) 3 times per day.
•Contraindications
- The contraindications of the drug are hypersensitivity to the drug or any other component of the formulation. There are not yet any known interactions with any drug, herbal, food and diagnostic test effects.
•Precautions
-Brinzolamide is not recommended for severe renal impairment. Caution is to be exercised in patients with hepatic impairment. Additive effects occur with oral CAI. Concomitant administration is not recommended. Instructions for the patients are to remove the contact lenses (if worn) and re-insert it 15 minutes after instillation. This drug is not recommended for pregnant ladies.
Dorzolamide
•Mechanism
-An ophthalmic agent that inhibits carbonic anhydrase. Its therapeutic effect help reduces the intraocular pressure, thus serving as a glaucoma drug.
-For patients with glaucoma and ocular hypertension, it is recommended for the adults to take in 1 drop in affected eye(s) 3 times per day
•Contraindications
-The contraindications are hypersensitivity to the drug itself or any other components of the formulation. The drug interacts with Topiramate, increasing the risk of nephrolithiasis. Otherwise, there are no other interactions with other herbal, food or diagnostic test effects.
•Precautions
-The drug is not recommended for patients with severe renal impairment. Caution is advised to be exercised accordingly in patients with hepatic impairment. Conjunctivitis and lid reactions were seemingly reported with chronic administration. Concomitant administration and oral CAI is not recommended. After filtration procedures, choroidal detachment might be observed. Discontinue the use of product upon serious or unusual reactions, signs of hypersensitivity, or patient develops any ocular reactions. The drug contains a type of chemical that could be absorbed by soft contact lenses. Hence, it is advisable for the patient to reinsert the lens 15 minutes following drug administration.
These prostaglandin-like drugs lower intraocular pressure by increasing the uveoscleral outflow of aqueous humor. They are very effective in reducing the eye pressure as the help relax the muscles in the eye’s interior structure to allow better outflow of fluids, hence reducing the build-up of eye pressure. Prostaglandins also have the advantage of requiring only once a day administration. They are often used in the form of eye drops. Reports have also strongly supported that prostaglandins have taken the lead in recent years as first-line therapy for glaucoma.
Bimatoprost
•Mechanism
-A synthetic analog of prostaglandin with ocular hypotensive activity. Its therapeutic effect is reducing intraocular pressure (IOP) by increasing the outflow of aqueous humor
•Clinical uses
-Reducing IOP
•Ocular effects
-Conjunctival hyperaemia
-Growth of eye lashes
-Ocular Pruritus(frequent)
-Ocular dryness
-Visual disturbance
-Ocular burning
-Foreign body sensation
-Pain
-Blepharitis
-Cateract
-Superficial punctate keratitis
-Eyelid erythema
-Darkening of Iris
-Intraocular inflammation(Rare)
-Pigmentation of periocular skin
•Indications
-1 drop in affected eye(s) once daily, in the evening.
•Contraindications
-The contraindications are hypersensitivity to Bimatoprost or any other components of the formulation. It has no interactions with any drug, herbal, food or diagnostic test effects
•Precautions
-Increased brown pigmentation of the iris may occur. Macular edema (Cystoid Macular Edema in aphakic and pseudophakic patients) may also occur. Caution is to be excercised appropriately with active intraocular inflammation (e.g, uveitis), renal or hepatic impairment. Bimatoprost is not to be administered while the patient is wearing contact lens. Patients are to remove their contact lenses before instillation of the drug and to reinsert the lenses 15 minutes after that
Lantanoprost
•Mechanism
-An ophthalmic agent that is a prostanoid selective FP receptor agonist. Its therapeutic effect helps reduce IOP by reducing aqueous humor production
-It’s mainly for glaucoma and ocular hypertension. For adults, the recommended dosage is 1 drop in affected eye(s) once daily, preferably in the evening
•Contraindications
-The contraindications are hypersensitivity to the drug or benzalkonium chloride, or any other component of the formulation. Its interactions with Pilocarpine and Thimerosal are decreasing of latanoprost efficacy and causing of precipitate in the eye respectively. There’re no other interactions with food, herbal, or diagnostic test effects.
•Precautions
-Patients may develop increased pigmentation of the iris. Caution is to be exercised upon patients with inflammation complains, renal or hepatic impairment. Macular edema may occur, especially to aphakic patients and pseudophakic patients. Upon contact lens wearing, do not administer the drug. Pregnant ladies are advised not to be prescribed with this drug.
Travoprost
•Mechanism
-An ophthalmic agent that is prostanoid selective FP agonist. Its therapeutic effect helps reduce IOP by reducing aqueous humor production
-It is mainly used for open-angle glaucoma, and ocular hypertension. The recommended dosage for adults/elderly is 1 drop in affected eye(s) once daily, in the evening
•Contraindications
-The contraindications are hypersensitivity to the drug itself or benzalkonium chloride, or any other component of the formulation. The drugs don’t show any interactions with any drug, food, herbal or diagnostic test effects.
•Precautions
-Patients may slowly develop increased brown pigmentation of the iris and this change might not be noticeable for months to years. Iris pigmentation changes may be more noticeable in patients with mixed colored irides (blue-brown, grey-brown, yellow-brown, and green-brown). Drugs also cannot be administered upon patient’s wearing contact lenses. Caution is to be exercised properly upon patients with renal or hepatic impairment. It is advisable for the patient to remove the contact lenses and reinsert it 15 minutes after the administration of the drug. If more than one topical ocular drug is used, we have to administer the drugs at least 5 minutes apart
Cholinergic are neurons which release Acetylcholine (Ach) in the parasympathetic nervous system.
Pilocarpine
•Mechanism
-It increases exocrine gland secretions by stimulating cholinergic receptors. It acts on a subtype of muscarinic receptor (M3), found on the iris sphincter muscle, causing the muscle to contract and engage in miosis, and it also acts on the ciliary muscle and causes it to contract. When the ciliary muscle contracts, it open the trabecular meshwork through the increased tension on the sclera spur. This action facilitates the rate that aqueous humor leaves the eye to decrease intraocular pressure
•Clinical uses
-Reduce the possibility glare at night from lights if the patient underwent implantation of phakic intraocular lenses
-Used to treat dry mouth (xerostomia)
-Used to constrict the pupil, to counteract the effect of mydriatic drugs such as atropine and phenylephrine
-Decrease the intra-ocular pressure in the treatment of open-angle and closed-angle glaucoma, and detachment of the retina
•Ocular effects
-Blurred vision
-Headache
-Increased tearing
-Redness or swelling of the eye
-Temporary stinging
-Burning sensation
•System effects
-Diaphoresis (Excessive sweating commonly associated with shock or other medical emergency conditions.)
-Urinary frequency increased
-Diarrhoea
-Abdomen pain
-Hypotension
-Bradycardia
•Indications
-Patients with intraocular hypertension and glaucoma
•Contraindications
-Patients suffering from bronchial asthma
Echothiophate iodide
•Mechanism
-It is a cholinesterase inhibitor that causes acetylcholine to accumulate at cholinergic receptor sites and produce effects like excessive stimulation of cholinergic receptors. It causes conjunctival hyperaemia and constriction of the sphincter pupillae and ciliary muscles, which result in miosis and paralysis of accommodation
•Clinical uses
-Used to treat chronic open-angle glaucoma
•Ocular effects
-Headache
-Blurred vision
-Burning and stinging of eyes
-Decreased night vision
-Intraocular pressure changes
-Iritis
-Uveitis
•Systemic effects
-Chest pain
-Diarrhoea
-Difficulty controlling your bladder
-Fast, slow, or irregular heartbeat
-Increased amount of saliva
-Muscle weakness
-Severe or unusual sweating
•Indications
-Patients with glaucoma and accommodative esotropia
•Contraindications
-Patients with active uveal inflammation
-Patients with angle-closure glaucoma
-Hypersensitivity to echothiophate products
Beta-adrenergic receptor blockers
Beta-adrenergic receptor blockers are also known as Beta adrenergic receptor antagonists, which are found in the sympathetic nervovs system that inhibits the release of norepinephrine from postganglionic adrenergic nerve endings. Examples of Beta-adrenergic receptor blockers are timolol, levobetaxolol, carteolol and metipranolol
Timolol
•Mechanism
-It is an antihypertensive, antimugraine, and antiglaucoma agent that blocks beta 1- and beta 2- adrenergic recopters
•Clinical uses
-Used to treat glaucoma
-Used to treat high blood pressure by lowering BP
-Decreased pressure of the eye
•Ocular effects
-Eye irritation
-Visual disturbance
•Systemic effects
Frequent:
-Diminished sexual function
-Drowsiness
-Difficulty sleeping
-Unusual tiredness or weakness
Occasional:
-Cold hands and feet
-Diarrhoea
-Constipation
-Anxiety
-Nasal congestion
-Nausea
•Indications
-Patients with mild to moderate hypertension
•Contraindications
-Patients with obstructive airways disease
-Heart failure
-Second and third degree atrioventricular block
Levobetaxolol
•Mechanism
-It is an antiglaucoma agent that blocks beta 1-adrenergic receptors. It reduces aqueous humor production and intraocular pressure (IOP). Levobetaxolol has fewer cardiovascular side effects than other beta blockers.
•Clinical uses
-Used in for lowering intraocular pressure (IOP) in patients with chronic open-angle glaucoma or ocular hypertension
-Patients with chronic open-angle glaucoma and ocular hypertension.
•Contraindications
-Sinus bradycardia
-Greater than a first degree atrioventricular block
-Cardiogenic shock
-Patients with overt cardiac failure
Carteolol
•Mechansim
-It is an antihypertensive that blocks beta 1- adrenergic receptors at normal doses and beta 2 – adrenergic receptors at large doses. Predominantly blocks beta 1 – adrenergic receptors in cardiac tissue
-Redness of eye or inside eyelids
-Decreased night vision
-Staining of cornea
-Blurred vision
-Increased light sensitivity
-Burning or stinging sensations
-Droopy eyelids
-Patients with obstructive pulmonary disease
-Cardiogenic shock
-Bronchial asthma
-Overt cardiac failure
-Second or third degree heart AV block
-Hypersensitivity to metipranolol
Pre-lecture tutorial questions
1. What is glaucoma
2. List 4 different types of glaucoma
3. What can increase the risk of getting glaucoma?
4. What are the glaucoma drugs available?
5. List the 5 systemic effects of Cholinergics.
Post-lecture tutorial questions
1. A patient complains of foggy vision, mild eye pain and sees halos around bright lights. He also indicated that he experiences headaches and nausea sometimes. At the same time, an increase in IOP (intraocular pressure) is observed. Name the possible condition. Name a type of drug that is useful to the treatment of this condition, and explain the mechanism of action of the drug.
2. How does timolol help treat glaucoma? Describe its mechanism of action
3. Describe the mechanism of β-adrenergic Receptor Antagonists.
4. Desribe laser and filter surgery. Which one is more commonly used?
5. What are the indications and contraindications of laser and filter surgery?
6. Which types of medical therapies should not be used when the patient is suffering from cardiovascular diseases?
7. List down the 3 mechanism of actions of Cholinergic medical therapy
8. Is filter surgery a permanent way to treat glaucoma? Why? Explain the mechanism together with your answer
9. When a patient is found having high IOP, which medical therapy should we avoid the most? Why?
10. List 5 types of drugs that are useful in the therapy of glaucoma. Choose one of the drugs that you would prescribe to a patient who is suffering from closed-angle glaucoma, and is suspected of retinal detachment, and name a generic name for the type of the drug. Explain why.